Business
ComBank posts impactful 9-month results with strong loan book growth
The Commercial Bank of Ceylon group has reported gross income of Rs. 268.49 Bn. and net interest income of Rs. 103.48 Bn. at the end of the third quarter of 2025, with strong year-on-year growth of 34.60% in the loan book and curtailed interest expenses contributing to an impressive nine-month performance.
Comprising of Sri Lanka’s largest private sector bank, its subsidiaries and an associate, the Group reported in a filing with the Colombo Stock Exchange (CSE) that interest income grew by 6.96% to Rs. 221.53 Bn. for the nine months ending 30th September 2025, while interest expenses for the period remained static at Rs. 118.05 Bn. as a result of the lower cost of funds and continuing improvement in the CASA ratio.
Consequently, net interest income at Rs. 103.48 Bn. for the nine months reviewed, grew by 16.30% in contrast to the 11.08% growth in gross income. In the third quarter, gross income grew by 16.37% to Rs. 91.46 Bn., while interest income for the three months improved by 10.35% to Rs. 74.88 Bn., with the loan book growing by 10.14% at a monthly average of Rs. 58.51 Bn.
“Our commitment to lending remains undiminished, because we believe that our capacity to support national economic growth targets must be fully leveraged within prudential limits” said Sharhan Muhseen, Chairman of Commercial Bank. “The group’s performance reflects the impacts of this approach, and we expect similar strong growth in the final quarter of the year, in line with the trajectory of economic and business recovery.”
Sanath Manatunge, Managing Director/CEO of Commercial Bank said the Bank’s ability to sustain growth in the loan book backed by a focus on yield management and cost optimization helped the Bank to post these strong results for the nine months reviewed. He said that the Bank maintained a strong focus on the CASA ratio, which stood at 39.92% as at 30th September 2025, compared to 38.07% at end December 2024 and 39.60% a year ago, helping the Bank to keep the cost of funds under control.
Total operating income increased by 21.41% to Rs. 140.49 Bn. for the nine months while the Group’s impairment charges and other losses for the period declined by 28.21% to Rs. 14.37 Bn., primarily due to the previous year’s figure including an additional provisioning for the Sri Lanka International Sovereign Bonds (SLISBs) held by the Bank. For the third quarter of 2025, the Group reported a total operating income of Rs. 47.74 Bn., an improvement of 24.13%.
The Group posted a net operating income of Rs. 126.13 Bn. for the nine months, reflecting an impressive growth of 31.79%, while keeping operating expenses at Rs. 39.41 Bn., an increase of only 8.00%, resulting in operating profit before taxes on financial services growing by a noteworthy 46.46% to Rs. 86.71 Bn.
Taxes on financial services increased by 50.72% to Rs. 13.36 Bn., leading to Group profit before income tax of Rs. 73.35 Bn. for the nine months with a growth of 45.71%. Income tax increased by 34.71% to Rs. 25.33 Bn., resulting in a net profit of Rs. 48.02 Bn. for the Group during the nine months reviewed, representing an impressive bottom-line growth of 52.27%. The Group reported a net profit of Rs. 16.86 Bn., recording an improvement of 33.38% for the third quarter of the year.
Taken separately, Commercial Bank of Ceylon PLC reported a profit before tax of Rs. 70.57 Bn. and profit after tax of Rs. 46.02 Bn. for the nine months reviewed, recording growths of 44.83% and 51.51% respectively.
Total assets of the Group increased by Rs 357 Bn. or 12.40% during the nine months to reach Rs. 3.233 Tn., as at 30th September 2025. Asset growth over the preceding 12 months was Rs. 469 Bn. or 16.99%.
The Group’s continued impetus in lending saw gross loans and advances growing by Rs. 381 Bn. or 25.01% over the nine months to Rs. 1.907 Tn., at a monthly average of Rs. 42.39 Bn. Loan book growth over the preceding 12 months was Rs. 490 Bn., with YoY growth of 34.60%, averaging Rs. 40.85 Bn. per month.
Deposits grew by 12.26% to Rs. 2.589 Tn. in the nine months, an increase of Rs. 283 Bn. at an average monthly growth of Rs 31.40 Bn., and recorded YoY growth of 16.27%, with monthly average growth of Rs 30.18 Bn., over the preceding 12 months.
In other key performance indicators, the Bank’s Tier 1 and Total Capital Ratios stood at 13.391% and 17.282% respectively as at 30th September 2025, both comfortably above the statutory minimum ratios applicable for the Bank of 10% and 14% respectively.
In terms of profitability, the Bank’s net interest margin increased to 4.53% for the nine months compared to 4.27% reported at end 2024 and 4.38% a year ago. The Bank’s return on assets (before tax) improved to 3.19% compared to 2.47% a year ago, while the return on equity improved to 21.03% from 17.42% as at 30th September 2024.
The Bank’s cost to income ratio excluding taxes on financial services stood at 27.95%, as against the normalized ratio of 33.85% for 2024, while the figure inclusive of taxes on financial services was 37.69% for the period, in comparison with the normalized ratio of 41.89% for the preceding year, when the effect of the net loss on restructuring of Sri Lanka International Sovereign Bonds is discounted.
In terms of asset quality, the Bank’s impaired loans (Stage 3) ratio improved further to 1.79% compared to 4.08% a year ago, while its impairment (Stage 3) to Stage 3 loans ratio for the reviewed period improved to 71.43%, as against 64.61% as at 31st December 2024 and 53.54% as at 30th September 2024.
Business
Asia stocks slide as US and Iran threaten to escalate war
Major stock markets in Asia slumped on Monday after Washington and Tehran threatened to escalate hostilities, as the Iran war enters its fourth week.
Japan’s benchmark Nikkei 225 index was almost 3.6% lower, while South Korea’s Kospi fell by almost 6%.
US President Donald Trump warned on Saturday that he would “obliterate” Iranian power plants if Iran did not open the key Strait of Hormuz shipping route. Iran said it would respond to any such strikes by targeting key infrastructure in the region, including energy facilities.
Japan and South Korea have been particularly impacted by the conflict, as they are heavily dependent on oil and gas that would normally pass through the strait.
Iran has effectively blocked the Strait of Hormuz, one of the world’s busiest shipping channels, since the US and Israel attacked the country on 28 February.
About 20% of the world’s oil and liquefied natural gas (LNG) usually passes through the waterway – and the war has sent global fuel prices soaring.
On Monday, International Energy Agency chief Fatih Birol said that the war could see the world facing its worst energy crisis in decades.
Speaking at the National Press Club in Australia’s capital, Birol compared the current energy crisis to those of the 1970s and the impact of Russia’s 2022 invasion of Ukraine.
“This crisis as things stand is now two oil crises and one gas crash put all together,” he said.

“If Iran doesn’t FULLY OPEN, WITHOUT THREAT, the Strait of Hormuz, within 48 HOURS from this exact point in time, the United States of America will hit and obliterate their various POWER PLANTS, STARTING WITH THE BIGGEST ONE FIRST!,” Trump said in a social media post published at 23:44 GMT Saturday.
That threat came after Iranian missiles hit the Israeli city of Dimona, and shortly before a second attack on the town of Arad nearby.
Mohammad Bagher Ghalibaf, the speaker of the Iranian parliament, said on Sunday that energy and desalination infrastructure in the region would be “irreversibly destroyed” if his country’s power plants were attacked.
Such action would significantly escalate the conflict, which has already disrupted global energy supplies, pushing up prices and causing fuel shortages.
Other markets in the Asia-Pacific region were also lower on Monday.
Hong Kong’s Hang was down by almost 3.5% and the Shanghai Stock Exchange Composite index 2.5% lower.
Global oil prices were broadly steady, with Brent crude 0.45% higher at $112.69 (£84.56) a barrel and US-traded oil was up by 0.7% at $98.93.
[BBC]
Business
Healthguard Distribution powers Sri Lanka’s ‘Port to Pharmacy’ medicine supply chain
Human resources remain the biggest challenge despite advanced logistics
Industry-wide cost pressures are also beginning to surface
In Sri Lanka’s pharmaceutical trade, the journey of a medicine does not end when it arrives at the port. It must still travel safely across the island – through regulated warehouses, temperature-controlled transport and complex distribution routes – before reaching the pharmacy shelf where patients need it.
That journey is increasingly being powered by Healthguard Distribution, the pharmaceutical logistics arm of Sunshine Holdings, whose expanding distribution network now plays a critical role in ensuring the reliable movement of medicines across the country.
At the centre of that network is the company’s Western Regional Distribution Centre (WRDC), a temperature-controlled logistics hub designed to support the safe storage and efficient distribution of pharmaceutical products across the Western Province.
Spanning nearly 18,920 square feet, the facility functions as a key node in the company’s islandwide distribution system. Originally acquired in 2008 to serve as the main warehouse for Swiss Biogenic Ltd., the site evolved alongside the company’s growing operations. Following a major upgrade programme that began in July 2024, the facility recommenced operations in July 2025 as a fully compliant regional distribution centre aligned with international quality standards.
According to Sunshine Pharmaceuticals and Healthguard Distribution Chief Executive Officer Shantha Bandara, the company’s logistics model is built around a simple but comprehensive concept.
“Our approach is ‘Port to Pharmacy’,” Bandara said during a recent media visit. “We collect pharmaceutical consignments from the Port of Colombo, clear them through Customs, store them under regulated conditions and then distribute them to pharmacies across the country. Importers and manufacturers do not have to worry about logistics – we manage the entire process.”
The distribution network today serves over 4,500 authorised pharmaceutical outlets, including pharmacies, hospitals, channeling centres, supermarkets and SPC Osusala outlets. Operations span 150 main towns and 466 sub towns, supported by 111 active delivery routes and seven regional distribution centres located across the island.
Within that system, the WRDC is the largest and among the most technologically advanced hubs.
The facility maintains strict cold-chain conditions for temperature-sensitive medicines. Its cold room capacity has been expanded from 15 cubic metres to 30 cubic metres, enabling compliant storage of products such as insulin within the required 2–8°C range. Online temperature monitoring systems operate across all storage zones while data loggers are used for insulin deliveries to ensure product integrity throughout the supply chain.
Delivery vehicles are also equipped with GPS tracking and temperature monitoring systems, allowing real-time visibility of shipments.
Automation and digital systems are increasingly shaping the operation. Software automation supports invoicing and customer credit verification, while sales teams use digital tools for order canvassing. The company’s enterprise systems provide real-time inventory and accounting visibility, supported by data dashboards used for operational decision-making.
To safeguard continuity, the facility is equipped with a high-capacity backup generator and dedicated on-site fuel storage, ensuring cold rooms, monitoring systems and warehouse operations remain functional even during power outages.
Behind the infrastructure is a workforce of 102 employees, supported by a specialised 15-member value-added services team trained in Good Distribution Practice (GDP), cold-chain management, safety and emergency response.
Yet despite the sophisticated logistics and infrastructure, Bandara told The Island that the most persistent operational challenge lies in human resources.
“We have the infrastructure, the logistics systems and the operational capability,” he noted. “However, maintaining the required number of skilled employees is an ongoing challenge because the labour market is constantly fluctuating. Our HR team is continuously recruiting and training to keep the workforce at the required level.”
Industry-wide cost pressures are also beginning to surface. Company officials noted that rising fuel prices could eventually affect transportation and electricity costs within the distribution chain, which may in turn influence pharmaceutical logistics expenses in the short term.
Still, the broader goal of the company remains unchanged – ensuring that medicines reach patients safely and on time.
From the moment a shipment arrives at the Port of Colombo to the point it reaches a pharmacy shelf, the process depends on precision logistics, regulatory compliance and operational discipline. For Sri Lanka’s healthcare supply chain, Healthguard Distribution’s growing network is becoming a key driver of that journey from port to pharmacy.
By Sanath Nanayakkare
Business
From generation to generation: SINGER secures 20th consecutive People’s Brand title
Singer Sri Lanka, the nation’s foremost retailer of consumer durables, celebrates a truly historic milestone at the SLIM-KANTAR People’s Awards 2026, securing a prestigious triple victory while marking 20 consecutive years as the People’s Brand of the Year, an achievement made possible by the enduring trust and loyalty of Sri Lankan consumers.
This year, SINGER was honoured with yet another triple win with People’s Brand of the Year, Youth Brand of the Year and People’s Durables Brand of the Year at the awards ceremony. This remarkable recognition reflects the deep and lasting relationship the brand has built with Sri Lankans across generations, standing as a symbol of trust in homes across the island.
Janmesh Antony, Director – Marketing said: “This award belongs to our customers. Being recognised as People’s Brand for 20 years, alongside Youth and Durables Brand, reflects our commitment to staying relevant across generations.”
Mahesh Wijewardene, Group Managing Director said: “Twenty consecutive years as the People’s Brand is humbling and inspiring. This milestone strengthens our commitment to keeping customers at the heart of everything we do.”
-
News6 days agoCIABOC questions Ex-President GR on house for CJ’s maid
-
News7 days agoSri Lankan marine scientist Asha de Vos honoured at UNGA opening
-
News7 days agoAustralian HC debunks misleading travel risk claims for Sri Lanka
-
News5 days agoBailey Bridge inaugurated at Chilaw
-
News5 days agoPay hike demand: CEB workers climb down from 40 % to 15–20%
-
News4 days agoCIABOC tells court Kapila gave Rs 60 mn to MR and Rs. 20 mn to Priyankara
-
Editorial6 days agoCouple QR-based quota with odd-even rationing
-
Features23 hours agoTrincomalee oil tank farm: An engineering marvel
